Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynairgen Share News (SNG)

  • There is currently no data for SNG

AIM WINNERS & LOSERS: Solid State order win; Synairgen plots AIM exit

Tue, 11th Mar 2025 10:25

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday.

----------

AIM - WINNERS

----------

Solid State PLC, up 14% at 200.00 pence, 12-month range 100.00p-308.00p. The electronics supplier for industry and defence announces it has received a USD25 million order for communications equipment "under a prominent defence order programme". It will be delivered in the next financial year, which concludes in March 2026. "This order was previously expected to be received and delivered in FY24/25, however as announced in November 2024, it was put on hold following the change in the UK government and pending the outcome of the strategic defence review. Whilst the defence review is expected to report in the spring, this order has been approved by exception," Solid State says. "Given recent geo-political developments, and in light of this order, the company intends to increase investment in the group's production capabilities in both the USA and the UK to accelerate medium term organic growth opportunities within the defence & security sector."

----------

AIM - LOSERS

----------

Synairgen PLC, down 34% at 1.32p, 12-month range 1.22p-10.00p. The respiratory biotech company plans to exit the AIM market after failing to secure the funds it pursued. Synairgen had looked to raise at least GBP2.9 million, in addition to a GBP18 million subscription from TFG Asset Management UK LLP. It explained that while GBP2.2 million worth of commitments were received, it did not meet its minimum target, so it is cancelling its AIM admission as a result. "The board believes that the cancellation is in the best interests of the company and its shareholders as a whole," it says.

----------

Facilities by ADF PLC, down 27% at 20.44p, 12-month range 18.40p-58.00p. Shares hit this 12-month low on Tuesday, as it warns on earnings. "Whilst at this early stage in the year revenue and profitability for FY25 are expected to be materially below current market expectations," it cautions. It puts market expectations for adjusted earnings before interest, tax, depreciation and amortisation at GBP15.8 million and forecasts for revenue at GBP56.8 million. The provider of production facilities for the film and television industry expects to report 2024 revenue of GBP35.2 million, with a GBP2.6 million boost from its Autotrak Portable Roadways acquisition done in September. The wider business achieves revenue that was "broadly flat" from GBP34.8 million in 2023. This was due to project delays following the Writers Guild of America and Screen Actors Guild - American Federation of Television & Radio Artists strikes from May to November 2023.

----------

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Related News

TRADING UPDATES: Character Group leases part of Infinity House
8 Apr 2026

TRADING UPDATES: Character Group leases part of Infinity House

(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance...

Synairgen News

AIM WINNERS & LOSERS: Solid State order win; Synairgen plots AIM exit
11 Mar 2025

AIM WINNERS & LOSERS: Solid State order win; Synairgen plots AIM exit

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday.

AIM WINNERS & LOSERS: Tiger Royalties to buy Bixby Technologies
20 Dec 2024

AIM WINNERS & LOSERS: Tiger Royalties to buy Bixby Technologies

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday.

EARNINGS: Hansard Global profit down; Flowtech cuts outlook
26 Sep 2024

EARNINGS: Hansard Global profit down; Flowtech cuts outlook

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Thursday and not separately reported by Alliance News...

IN BRIEF: Synairgen slashes costs and focuses on small hospital trials
27 Jun 2024

IN BRIEF: Synairgen slashes costs and focuses on small hospital trials

Synairgen PLC - South Hampton, England-based drug discovery and development company focused on combatting respiratory disease - In 2023, pretax loss n...

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered
7 May 2024

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

IN BRIEF: Synairgen names Phytome's Joseph Colliver as CFO
11 Oct 2023

IN BRIEF: Synairgen names Phytome's Joseph Colliver as CFO

Synairgen PLC - Southampton, England-based drug discovery and biotechnology firm developing SNG001 antiviral treatment for lung infections - Appoints ...

Synairgen names Joseph Colliver as CFO
11 Oct 2023

Synairgen names Joseph Colliver as CFO

(Sharecast News) - Drug discovery firm Synairgen revealed on Wednesday that it had tapped Joseph Colliver to take over as chief financial officer.